Autologous mucosal transplant in chronic spinal cord injury: an Indian Pilot Study
Tóm tắt
Từ khóa
Tài liệu tham khảo
Mackay-Sim A, Féron F, Cochrane J, Bassingthwaighte L, Bayliss C, Davies W et al. Autologous olfactory ensheathing cell transplantation in human paraplegia: a 3-year clinical trial. Brain 2008; 131 (Pt 9): 2376–2386.
Lima C, Pratas-Vital J, Escada P, Hasse-Ferreira A, Capucho C, Peduzzi JD . Olfactory mucosa autografts in human spinal cord injury: a pilot clinical study. J Spinal Cord Med 2006; 29: 191–203.
Syková E, Homola A, Mazanec R, Lachmann H, Konrádová SL, Kobylka P et al. Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury. Cell Transplant 2006; 15: 1–100.
Huang H, Chen L, Wang H, Xi H, Gou C, Zhang J et al. Safety of fetal olfactory ensheathing cell transplantation in patients with chronic spinal cord injury. A 38-month follow-up with MRI. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2006; 20: 439–443.
Huang H, Chen L, Wang H, Xiu B, Li B, Wang R et al. Influence of patients’ age on functional recovery after transplantation of olfactory ensheathing cells into injured spinal cord injury. Chin Med J (Engl) 2003; 116: 1488–1491.
Huang H, Wang H, Chen L, Gu Z, Zhang J, Zhang F et al. Influence factors for functional improvement after olfactory ensheathing cell transplantation for chronic spinal cord injury. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2006; 20: 434–438.
Park HC, Shim YS, Ha Y, Yoon SH, Park SR, Choi BH et al. Treatment of complete spinal cord injury pateints by autologous bone marrow cell transplantation and administration of granulocyte-macrophage colony stimulating factor. Tissue Eng 2005; 11: 913–922.
Knoller N, Auerbach G, Fulga V, Zelig G, Attias J, Bakimer R et al. Clinical experience using incubated autologous macrophages as a treatment for complete spinal cord injury: phase I study results. J Neurosurg Spine 2005; 3: 173–181.
Yoon SH, Shim YS, Park YH, Chung JK, Nam JH, Kim MO et al. Complete spinal cord injury treatment using autologus bone marrow cell transplantation and bone marow stimulation with granulocyte macrophage-colony stimulating factor: phase I/II clinical trial. Stem Cell 2007; 25: 2066–2073.
Ramon-Cueto A, Nieto-Sampedro M . Regeneration into the spinal cord of transected dorsal root axons is promoted by ensheathing glia transplants. Exp Neurol 1994; 127: 232–244.
Doucette R . Olfactory ensheathing cells: potential for glial cell transplantation into areas of CNS injury. Histol Histopathol 1995; 10: 503–507.
Gudino-Cabrera G, Nieto-Sampedro M . Schwann-like microglia in adult rat brain. Glia 2000; 30: 49–63.
Feron F, Perry C, Cochrane J, Licina P, Nowitzke A, Urquhart S et al. Autologous olfactory ensheathing cell transplantation in human spinal cord injury. Brain 2005; 128: 2951–2960.
Ronsyn MW, Berneman ZN, Tendeloo VFI, Jorens PG, Ponsaerts P . Can cell therapy heal a spinal cord injury? Spinal Cord 2008; 46: 532–539.
Roisen FJ, Klueber KM, Lu CL, Hatcher LM, Dozier A, Shields CB et al. Adult human olfactory stem cells. Brain Res 2001; 890: 11–22.
Xiao M, Klueber KM, Lu C, Guo Z, Wang H, Roisen FJ . Human adult olfactory neural progenitors rescue axotomized rodent rubrospinal neurons and promote functional recovery. Exp Neurol 2005; 194: 12–30.
Mumm JS, Shou J, Calof AL . Colony-forming progenitors from mouse olfactory epithelium: evidence for feedback regulation of neuron production. Proc Natl Acad Sci USA 1996; 93: 11167–11172.
Lu J, Feron F, Ho SM, Mackay-sim A, Waite PM . Transplantation of nasal olfactory tissue promotes partial recovery in paraplegic adult rats. Brain Res 2001; 889: 344–357.
Murrell W, Féron F, Wetzig A, Cameon N, Splatt K, Bellette B et al. Multipotent stem cells from adult olfactory mucosa. Dev Dyn 2005; 233: 496–515.
Iwatsuki K, Yoshimine T, Kishima H, Aoki M, Yoshimura K, Ishihara M et al. Transplantation of olfactory mucosa following spinal cord injury promotes recovery in rats. Neuroreport 2008; 19: 1249–1252.
Tuszynski MH, Steeves JD, Fawcett JW, Lammertse D, Kalichman M, Rask C et al. Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP Panel: clinical trial inclusion exclusion criteria and ethics. Spinal Cord 2007; 45: 222–231.
Nakashima T, Kimmeiman CP, Snow JB . Structure of human fetal and adult olfactory neuroepithelium. Arch Otolaryngol 1984; 110: 641–646.
Fawcett JW, Curt A, Steeves JD, Coleman WP, Tuszynski MH, Lammertse D et al. Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP Panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials. Spinal Cord 2007; 45: 190–205.
Steeves JD, Lammertse D, Curt A, Fawcett JW, Tuszynski MH, Ditunno JF et al. Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP Panel: clinical trial outcome measures. Spinal Cord 2007; 45: 206–221.
Lammertse D, Tuszynski MH, Steeves JD, Curt A, Fawcett JW, Rask C et al. Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP Panel: clinical trial design. Spinal Cord 2007; 45: 232–242.
Curt A, Van Hedel HJ, Klaus D, Dietz V . Recovery from a spinal cord injury: significance of compensation, neural plasticity, and repair. J Neurotrauma 2008; 25: 677–685.